<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.958" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">491</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 219.300 L106.100 219.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="77.103" x="113.617,118.801,121.798,125.794,129.79,132.292,139.294,143.29,147.79,150.292,152.038,158.536,161.038,163.54,168.04,169.786,172.783,175.285,179.785,184.285,188.785,191.287,193.789,200.791,205.291,209.791,211.537,214.039,218.035,222.031,226.531,230.032,231.778,234.28,238.78,240.526,244.522,246.268,253.27,257.266,260.263,264.763,268.759,273.259,275.005,278.002,281.998,286.498,290.998,294.994" svgx:width="0.61,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.44,0.25,0.78,0.44,0.33,0.5,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Treatment with fingolimod leads to a marked reduc-</text>
   <text y="88.101" x="62.362,64.864,67.366,71.866,76.366,78.733,83.233,86.23,88.597,91.099,95.599,102.601,107.101,111.601,116.101,120.097,124.597,127.099,131.095,134.596,136.963,139.465,143.965,146.332,148.834,153.334,157.33,159.697,164.197,168.193,171.19,173.692,178.192,182.692,186.688,189.685,193.681,196.183,198.55,203.05,205.552,210.052,214.552,219.052,221.302,223.669,230.167,234.163,237.16,241.156,243.406,245.773,252.271,256.267,258.634,263.134,266.131,270.127,273.628,277.624,282.124,284.626,286.993,289.495,293.995,297.991" svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.25,0.72,0.44,0.33,0.44,0.25,0.25,0.72,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion of lymphocytes in the peripheral blood. Here, we present the </text>
   <text y="99.099" x="62.362,65.359,67.861,70.858,74.359,76.861,79.462,82.963,85.465,89.965,94.465,98.965,101.566,104.068,108.568,112.564,115.066,117.667,122.167,125.668,129.664,134.164,136.765,141.265,143.767,148.267,152.767,155.764,158.761,162.757,166.258,170.758,173.26,177.76,180.262,182.764,187.264,191.764,194.365,198.865,202.861,207.361,211.357,213.958,217.954,222.454,226.954,229.951,233.947,237.448,240.949,243.451,247.951,252.451,255.052,262.054,264.556,268.552,271.549,276.049,280.045,283.042,286.039,290.035,294.535,298.036" svgx:width="0.33,0.28,0.33,0.39,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.5,0.39,0.44,0.5,0.25,0.5,0.28,0.5,0.5,0.33,0.33,0.44,0.39,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.78,0.28,0.44,0.33,0.5,0.44,0.33,0.33,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">first study that used high-resolution gene expression microarrays </text>
   <text y="110.097" x="62.362,64.864,69.364,71.614,72.631,76.627,81.127,85.123,87.625,92.125,96.121,100.117,102.367,103.384,107.884,112.384,118.882,121.132,122.149,124.651,129.151,133.147,135.397,136.414,143.416,147.916,150.418,154.414,158.41,162.91,165.412,169.408,172.405,174.655,175.672,180.172,183.169,187.669,192.169,196.165,199.162,201.664,204.166,208.162,211.663,213.913,214.93,219.43,222.427,224.677,225.694,228.196,234.694,239.194,241.444,242.461,246.961,249.463,252.298,255.295,259.291,262.288,266.284,270.784,273.286,275.536,276.391,281.728,283.978,284.995,288.991,292.987,295.489,297.991" svgx:width="0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.25,0.55,0.5,0.5,0.72,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.72,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.55,0.61,0.25,0.55,0.44,0.44,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to analyze how the molecular properties of two different T cell </text>
   <text y="121.095" x="62.362,65.863,70.363,74.863,78.364,82.36,84.862,88.363,90.235,94.231,97.228,101.224,103.096,110.098,114.598,119.098,123.598,126.1,130.096,132.598,136.594,141.094,142.966,147.466,151.966,154.963,157.465,161.965,166.465,168.337,170.839,175.339,179.335,182.332,186.328,190.828,194.743,196.993,198.703,204.04,205.912,209.908,213.904,216.406,218.908,220.78,224.776,228.772,231.274,233.776,238.276,242.272,244.774,247.276,251.776,256.276,258.148,262.648,266.644,271.144,275.14,278.641,280.513,287.011,291.007,294.004,298.0" svgx:width="0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25,0.44,0.33,0.44,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">subsets are modulated during therapy. T cell activation genes were </text>
   <text y="132.093" x="62.362,66.862,69.364,72.199,75.196,79.192,82.189,86.185,90.685,93.187,95.689,99.685,102.187,104.689,109.189,111.925,115.921,120.421,124.921,127.918,131.914,135.415,138.916,142.912,147.412,150.148,152.65,157.15,159.886,164.386,168.886,171.388,175.888,178.624,182.62,186.616,189.118,191.62,194.356,196.858,201.358,205.858,209.854,213.355,215.605,218.341,222.841,227.341,229.843,232.579,235.081,239.581,242.317,246.817,250.813,255.313,259.309,262.306,266.302,268.804,271.54,276.04,278.542,282.043,284.545,287.047,291.547,295.543,298.045" svgx:width="0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.44,0.44,0.28,0.28,0.25,0.28,0.5,0.5,0.44,0.39,0.25,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.5,0.28,0.39,0.28,0.28,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">differentially expressed in both cell types, but in general distinct </text>
   <text y="143.091" x="62.362,66.862,69.364,73.864,76.366,80.866,85.366,87.868,91.864,95.86,98.362,100.612,102.412,106.912,109.909,114.409,118.405,122.401,125.902,129.403,133.399,136.9,139.15,140.95,147.448,151.444,154.441,158.437,160.687,162.478,166.474,169.309,172.306,176.302,180.298,182.8,186.796,191.296,193.546,195.346,197.848,202.348,204.598,206.398,209.395,213.391,216.892,221.392,225.892,230.392,233.893,237.889,240.139,241.93,244.432,248.932,251.182,252.982,255.484,258.481,262.477,266.473,268.975,275.977,279.973,284.473,286.975,289.225,291.016,293.518,298.018" svgx:width="0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">biological processes were affected in response to treatment in </text>
   <text y="154.089" x="62.362,68.365,74.863,79.363,84.439,86.689,90.685,95.185,99.685,101.935,107.938,114.436,118.936,124.012,126.1,131.437,133.687,137.683,141.679,144.181,146.683,150.184" svgx:width="0.67,0.72,0.5,0.56,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.5,0.56,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD4+ and CD8+ T cells.</text>
   <text y="185.085" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P970</text>
   <text y="196.083" x="62.362,65.863,73.36,80.857,85.861,90.865,95.365,99.865,102.367,106.867,111.871,116.875,119.377,121.879,126.883,129.133,132.13,136.63,144.127,146.629,149.131,153.631,155.881,160.381,164.377,169.381,173.377,176.878,179.128,183.628,187.624,191.62,193.87,198.37,201.871,205.372,209.872,213.868,216.37,220.87,223.867,227.863,232.867,235.117,241.615,244.117,247.114,252.118" svgx:width="0.39,0.83,0.83,0.56,0.56,0.5,0.5,0.28,0.5,0.56,0.56,0.28,0.28,0.56,0.25,0.33,0.5,0.83,0.28,0.28,0.5,0.25,0.5,0.44,0.56,0.44,0.39,0.25,0.5,0.44,0.44,0.25,0.5,0.39,0.39,0.5,0.44,0.28,0.5,0.33,0.44,0.56,0.25,0.72,0.28,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Immunoglobulin family genes are associated with </text>
   <text y="207.081" x="62.362,66.358,68.86,71.362,76.366,78.868,82.864,87.364,89.866,92.116,96.112,100.108,103.609,108.613,113.113,118.117,121.618,125.614,127.864,130.861,135.361,137.611,142.615,147.115,150.112,154.612,157.114,159.616,163.612,168.616,176.113,180.613" svgx:width="0.44,0.28,0.28,0.56,0.28,0.44,0.5,0.28,0.25,0.44,0.44,0.39,0.56,0.5,0.56,0.39,0.44,0.25,0.33,0.5,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">clinical response to natalizumab</text>
   <text y="218.079" x="62.362,70.363,72.613,79.111,83.611,86.608,90.604,95.104,97.606,101.602" svgx:width="0.89,0.25,0.72,0.5,0.33,0.44,0.5,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M Gurevich</text>
   <text y="215.583" x="106.102" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="218.103" x="109.027,111.277,113.527,120.025,122.275,130.276,132.778,135.775,140.275" svgx:width="0.25,0.25,0.72,0.25,0.89,0.28,0.33,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Miron</text>
   <text y="215.583" x="144.774" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="218.103" x="147.699,149.949,152.199,157.698,159.948,166.446,170.442,174.942,178.938,182.934" svgx:width="0.25,0.25,0.61,0.25,0.72,0.44,0.5,0.44,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Hanael</text>
   <text y="215.583" x="185.436" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="218.103" x="188.361,190.611,192.861,197.865,200.115,205.119,209.619,214.119,216.621" svgx:width="0.25,0.25,0.56,0.25,0.56,0.5,0.5,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Sonis</text>
   <text y="215.583" x="220.122" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="218.103" x="223.047,225.297,227.547,235.548,237.798,244.296,248.796,251.298,255.294" svgx:width="0.25,0.25,0.89,0.25,0.72,0.5,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Dolev</text>
   <text y="215.583" x="259.793" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="218.103" x="262.718,264.968,267.218,273.716" svgx:width="0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D </text>
   <text y="229.101" x="62.36,70.361,74.357,78.857,82.853,85.355,89.351,92.852,97.352,101.852,104.354,106.856" svgx:width="0.89,0.44,0.5,0.44,0.28,0.44,0.39,0.5,0.5,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Magalashvili</text>
   <text y="226.583" x="109.36" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="229.103" x="112.285,114.535,116.785,123.283,125.533,132.031,136.027,140.527,143.029,146.026,150.526" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.5,0.28,0.33,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Achiron</text>
   <text y="226.583" x="155.025" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="237.581" x="62.361" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="240.103" x="65.287,69.787,74.287,78.283,82.783,87.283,89.533,97.03,101.026,105.526,108.028,112.024,116.524,119.026,121.276,127.279,131.275,135.775,138.277,142.273,145.774,148.024,150.274,157.771,162.271,164.773,167.275,169.777,174.277,176.779,180.775,183.025,187.525,191.521,194.023,198.019,201.52,206.02,209.521,212.023,215.524,217.774,223.777,227.773,232.273,234.775,238.771,242.272,244.522,246.772,252.271,256.771,263.269,267.769,270.271,272.521,279.019,283.519,288.019,290.269" svgx:width="0.5,0.5,0.44,0.5,0.5,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.5,0.72,0.5,0.28,0.25,0.72,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Sheba Medical Center, Multiple Sclerosis Center, Ramat Gan, </text>
   <text y="251.101" x="62.362,65.359,68.86,72.361,76.861,80.857" svgx:width="0.33,0.39,0.39,0.5,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Israel</text>
   <text y="278.101" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="278.101" x="116.623,123.121,127.117,129.619,133.615,136.117,138.619,142.615,147.115,154.117,158.113,162.613,164.863,167.113,168.778,172.774,175.024,176.689,181.189,185.689,192.691,196.687,201.187,203.689,207.685,211.681,216.181,218.431,220.096,227.098,231.598,236.098,240.598,244.594,247.096,251.596,256.096,260.092,262.594,264.844,266.509,270.505,275.005,277.507,280.009,284.509,289.009,293.509,298.009" svgx:width="0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.44,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natalizumab, a humanized monoclonal antibody </text>
   <text y="289.099" x="62.362,66.862,69.859,73.855,78.355,82.351,86.851,89.353,92.854,95.554,99.55,104.05,106.552,109.549,113.545,118.045,122.041,125.542,129.538,132.04,134.542,139.042,143.542,146.242,150.742,153.739,156.277,161.614,164.314,168.31,172.81,177.31,180.01,186.013,188.713,192.709,196.705,199.207,201.709,205.21,207.91,210.412,214.912,217.414,221.914,224.614,227.116,231.616,235.612,238.312,244.315,248.311,252.811,255.313,258.31,262.306,264.808,267.508,274.006,278.002,280.999,285.499,289.999,294.499,298.0" svgx:width="0.5,0.33,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.28,0.33,0.44,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.61,0.25,0.44,0.5,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.67,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.72,0.44,0.33,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">prevents extravasation of T and B cells into the Central Nervous </text>
   <text y="300.097" x="62.362,67.366,71.866,75.367,77.869,81.865,88.867,91.117,92.323,96.319,100.819,105.319,107.569,108.775,111.772,115.768,120.268,124.768,128.764,132.76,136.261,138.511,139.717,142.219,146.719,149.716,152.218,156.214,163.216,170.218,174.214,176.716,181.216,184.213,188.713,190.963,192.169,194.671,201.673,208.675,213.175,217.675,221.671,223.921,225.127,228.124,232.12,236.116,240.112,242.614,245.116,249.616,254.116,256.366,257.572,260.074,264.574,266.824,268.03,275.032,279.532,282.034,284.536,287.038,291.538,294.04,298.036" svgx:width="0.56,0.5,0.39,0.28,0.44,0.78,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.44,0.39,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">System and reduces inflammatory immune reaction in multiple </text>
   <text y="311.095" x="62.362,65.863,69.859,72.361,76.357,79.354,83.854,87.355,89.857,93.358,95.608,96.391,99.388,107.389,112.393,115.39,117.64,120.511,126.01,130.51,134.506,137.503,141.499,145.999,150.499,152.749,153.532,160.03,162.532,165.034,169.534,171.784,172.567,179.065,183.061,185.563,189.559,192.061,194.563,198.559,203.059,210.061,214.057,218.557,220.807,221.59,224.092,227.593,229.843,230.626,235.126,237.628,242.128,246.628,249.13,253.63,255.88,256.663,260.659,263.494,266.491,270.487,274.483,276.985,279.487,283.987,287.983,290.233,291.016,293.518,298.018" svgx:width="0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.5,0.28,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sclerosis (MS). Therapy with Natalizumab is highly effective in </text>
   <text y="322.093" x="62.362,65.359,69.355,71.857,75.853,80.353,83.854,86.356,90.856,95.356,97.606,99.505,102.502,106.498,113.5,116.002,118.504,121.006,123.508,128.008,132.508,134.758,136.657,144.658,149.662,151.912,153.811,156.808,162.811,168.814,176.815,181.819,184.816,187.066,189.316,191.215,195.715,200.215,206.713,210.709,215.209,219.205,222.202,224.452,226.351,228.853,233.353,237.853,240.355,244.855,247.357,251.857,256.357,260.353,262.855,265.105,267.004,271.504,275.5,278.002,280.504,284.5,289.0,291.502,295.003,298.0" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.25,0.55,0.5,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapsing remitting MS (RRMS), however individual patients´ </text>
   <text y="333.091" x="62.362,66.358,68.86,71.362,75.862,78.364,82.36,86.356,88.858,91.108,94.609,97.606,101.602,105.103,109.603,114.103,118.603,122.104,126.1,128.35,131.851,138.853,142.849,147.349,149.599,153.1,157.096,161.596,166.096,168.598,173.098,175.6,178.102,180.352,183.853,188.353,192.349,195.346,197.848,201.844,206.344,208.846,211.348,213.85,216.352,220.267,222.517,224.767,228.268,234.766,239.266,243.766,247.762,250.759,254.26,256.762,260.758,265.258,269.758,272.26,276.76,281.26,283.51,287.011,289.513,294.013,298.009" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.28,0.28,0.25,0.55,0.5,0.44,0.33,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.55,0.72,0.5,0.5,0.44,0.33,0.39,0.28,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical response may exhibit variability. Understanding the </text>
   <text y="344.089" x="62.362,66.862,71.362,75.862,79.858,82.855,85.357,89.857,92.359,96.859,101.359,103.609,105.553,112.555,117.055,119.557,123.553,127.549,132.049,134.551,138.547,141.544,143.794,145.738,152.74,156.736,160.732,165.232,169.228,173.728,176.23,179.731,186.733,190.234,192.484,194.428,198.928,201.925,204.175,206.119,210.619,215.119,217.621,220.123,227.125,231.121,233.623,235.873,237.817,241.813,246.313,250.813,253.063,255.007,258.508,263.008,267.508,270.505,275.005,279.505,282.007,284.509,291.511,295.507,298.009" svgx:width="0.5,0.5,0.5,0.44,0.33,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.28,0.28,0.78,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.33,0.5,0.5,0.28,0.28,0.78,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">underlying molecular mechanisms of optimal and sub-optimal </text>
   <text y="355.087" x="62.362,66.358,68.86,71.362,75.862,78.364,82.36,86.356,88.858,91.108,94.105,98.101,101.602,106.102,110.602,115.102,118.603,122.599,124.849,131.851,135.847,140.347,142.597,145.099,149.095,153.091,157.591,159.841,162.343,166.843,169.093,173.593,177.589,180.091,182.593,186.589,189.586,191.836,196.336,200.332,202.834,205.336,209.332,213.832,216.334,219.835,222.832,225.082,232.084,236.08,240.58,244.576,249.076,253.072,260.074,264.07,268.57,271.072" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.78,0.44,0.5,0.25,0.28,0.44,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.33,0.25,0.78,0.44,0.5,0.44,0.5,0.44,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical response may lead to better patients´ management.</text>
   <text y="366.085" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="366.085" x="107.947,113.446,117.946,121.942,124.444,128.944,132.94,135.442,139.438,141.535,146.035,148.537,153.037,157.537,162.037,164.134,168.634,172.63,177.13,181.126,183.223,187.219,191.719,196.219,199.216,203.212,206.713,210.214,212.716,217.216,221.716,223.813,228.313,230.815,235.315,242.317,246.313,249.31,253.81,257.806,260.803,264.304,266.401,269.398,273.898,276.895,278.992,285.994,290.494,294.994" svgx:width="0.61,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.28,0.5,0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.25,0.33,0.5,0.33,0.25,0.78,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Evaluate blood gene expression biomarkers for mon-</text>
   <text y="377.083" x="62.362,64.864,67.366,71.866,74.863,77.365,81.865,86.365,88.615,90.388,94.384,96.886,99.388,103.888,106.39,110.386,114.382,116.884,119.134,120.907,123.904,127.9,131.401,135.901,140.401,144.901,148.402,152.398,154.648,156.421,158.923,163.423,165.673,167.446,173.944,177.94,180.442,184.438,186.94,189.442,193.438,197.938,204.94,208.936,213.436,215.686,217.459,219.961,222.958,226.954,230.95,233.452,240.454,244.45,248.95,251.452,253.702,255.475,257.977,262.477,264.727,266.5,270.001,276.004,278.254,280.027,284.527,287.029,290.026,294.526,298.027" svgx:width="0.28,0.28,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.67,0.25,0.55,0.5,0.28,0.33,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">itoring clinical response to Natalizumab treatment in JC virus </text>
   <text y="388.081" x="62.362,66.862,70.858,75.358,79.354,81.856,84.358,88.858,92.854,95.104,101.107,107.11,115.111,120.115,122.365,126.865,130.861,133.363,135.865,139.861,144.361,146.863,150.364" svgx:width="0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">negative RRMS patients.</text>
   <text y="399.079" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="399.079" x="107.101,113.104,115.354,121.348,123.85,128.35,130.852,134.848,137.35,139.6,145.594,150.094,153.091,155.341,161.335,165.835,170.335,174.835,177.085,183.079,187.579,191.575,196.075,200.071,202.321,208.315,212.311,216.811,221.311,224.308,228.304,231.805,235.306,237.808,242.308,246.808,249.058,255.052,262.054,264.556,268.552,271.549,276.049,280.045,283.042,286.039,290.035,294.535,298.036" svgx:width="0.72,0.25,0.55,0.28,0.5,0.28,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.78,0.28,0.44,0.33,0.5,0.44,0.33,0.33,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A total of 132 gene expression microarrays </text>
   <text y="410.077" x="62.362,65.359,68.356,74.854,81.352,84.349,90.847,95.347,99.847,104.347,110.845,113.842,118.342,120.826,127.324,130.159,133.156,137.656,144.658,148.654,151.156,154.153,156.655,161.155,163.405,164.134,167.131,171.631,175.627,177.877,180.127,183.124,185.374,186.103,192.601,196.597,199.594,203.59,205.84,206.569,211.069,215.569,218.071,222.067,224.569,229.069,233.065,237.565,239.815,240.544,243.541,246.538,251.038,258.04,260.29,261.019,265.519,270.019,272.269,272.998,279.001,285.004,293.005,298.009" svgx:width="0.33,0.33,0.72,0.72,0.33,0.72,0.5,0.5,0.5,0.72,0.33,0.5,0.25,0.72,0.33,0.33,0.5,0.78,0.44,0.28,0.33,0.28,0.5,0.25,0.55,0.33,0.5,0.44,0.25,0.25,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">((HU-A133A-2 Affymetrix Inc.,) were obtained from 66 RRMS </text>
   <text y="421.075" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.611,94.177,98.677,103.177,104.743,107.74,111.736,118.738,122.734,125.236,129.232,132.733,134.983,136.549,140.545,145.045,149.041,150.607,155.107,159.607,161.857,166.357,171.298,175.798,178.048,182.548,184.114,188.614,192.61,196.606,199.603,203.104,205.354,206.92,211.42,213.922,217.423,221.419,225.415,228.916,232.912,234.478,238.978,243.478,246.475,250.471,252.973,255.475,259.975,264.475,266.041,270.541,275.041,277.291,281.791,286.732,291.232,293.482,297.982" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.5,0.5,0.25,0.33,0.44,0.78,0.44,0.28,0.44,0.39,0.25,0.25,0.44,0.5,0.44,0.25,0.5,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients, 50 females, age 38.9±1.1 years, disease duration 12.7±0.6 </text>
   <text y="432.073" x="62.362,66.862,70.858,74.854,77.851,81.352,83.683,87.679,92.179,96.679,99.01,104.509,111.007,116.011,121.015,123.346,127.846,130.096,134.596,139.537,144.037,146.287,150.787,153.037,155.368,160.867,164.863,168.859,173.359,175.69,180.19,184.186,186.688,189.19,193.186,197.686,200.188,202.519,209.017,213.013,216.514,218.845,222.346,226.342,233.344,237.844,240.346,244.342,248.842,251.173,255.673,259.669,262.666,267.166,270.163,274.159,276.49,278.992,283.492,285.994,288.496,290.998,294.994" svgx:width="0.5,0.44,0.44,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.25,0.61,0.44,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.72,0.44,0.39,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.5,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">years and EDSS 3.8±0.2. Each patient was sampled before initia-</text>
   <text y="443.071" x="62.362,64.864,67.366,71.866,76.366,79.111,83.611,86.608,89.353,95.851,99.847,102.349,106.345,108.847,111.349,115.345,119.845,126.847,130.843,135.343,138.088,142.084,146.584,151.084,153.829,158.329,162.829,166.825,169.57,174.07,178.066,182.062,185.059,187.804,190.306,194.806,198.802,201.799,205.795,209.791,212.788,215.29,219.286,221.788,224.038,226.783,233.281,237.781,240.283,242.785,249.787,253.783,256.285,259.03,262.027,266.023,269.524,274.024,278.524,283.024,287.524,291.52,294.517,298.018" svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.44,0.25,0.5,0.44,0.44,0.33,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.33,0.28,0.44,0.33,0.25,0.25,0.72,0.5,0.28,0.28,0.78,0.44,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion of Natalizumab and one year thereafter. Optimal responders </text>
   <text y="454.069" x="62.362,68.86,72.856,75.853,79.849,82.099,85.06,89.56,93.556,96.553,99.055,103.555,107.551,112.051,114.301,117.262,121.258,124.759,127.009,129.97,132.967,136.963,139.465,143.461,147.961,151.462,155.458,157.708,160.669,163.666,166.663,170.659,174.655,176.905,179.866,183.862,188.362,192.862,195.112,198.073,202.573,205.075,208.576,212.572,217.072,219.574,222.076,224.578,227.08,231.58,233.83,236.791,241.291,244.288,248.788,253.288,256.285,260.281,263.782,267.283,269.785,274.285,278.785,281.035,283.996,286.993,289.99,293.986,297.982" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.33,0.33,0.44,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.33,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were defined as relapse free and disability progression free </text>
   <text y="465.067" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.485,96.481,100.981,105.481,107.605,111.601,113.725,118.225,122.221,126.721,130.717,132.832,136.828,141.328,145.828,148.825,152.821,156.322,159.823,162.325,166.825,171.325,173.449,177.949,180.946,185.446,188.443,190.945,193.447,197.443,199.567,204.067,207.064,209.188,211.69,216.19,218.692,222.193,224.317,228.817,231.814,236.314,240.814,245.314,247.438,253.936,257.932,261.433,263.557,267.553,272.053,276.049,278.551,283.051,287.047,289.549,293.545,298.045" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients and a gene expression profile of this group was evaluated </text>
   <text y="476.065" x="62.362,66.862,71.362,73.612,74.431,78.931,82.927,85.429,88.426,92.422,96.922,99.172,99.991,102.493,105.49,107.992,111.988,115.489,117.991,120.241,122.491,123.31,129.808,133.804,138.304,142.3,145.801,148.051,148.87,155.368,157.87,160.372,164.872,167.122,167.941,172.441,177.517,179.767,180.586,185.086,187.336,191.836,196.336,198.586,199.405,203.401,206.398,208.9,212.896,215.893,218.143,218.962,224.965,229.465,233.965,236.962,240.958,243.955,246.952,251.452,255.952,258.454,260.704,261.523,265.519,270.019,273.016,276.013,280.009,284.005,286.507,289.009,293.509,298.009" svgx:width="0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.33,0.44,0.5,0.25,0.55,0.28,0.33,0.28,0.44,0.39,0.28,0.25,0.25,0.55,0.72,0.44,0.5,0.44,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.67,0.5,0.5,0.33,0.44,0.33,0.33,0.5,0.5,0.28,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">by paired t-test. Genes with p&lt; 0.05 after Bonferroni correction </text>
   <text y="487.063" x="62.362,68.86,72.856,75.853,79.849,82.099,83.098,87.598,91.594,94.591,97.093,101.593,105.589,110.089,112.339,113.338,117.334,120.835,123.085,124.084,131.086,135.586,139.087,141.589,143.839,144.838,147.34,151.84,154.837,159.337,162.334,169.336,173.332,175.834,178.336,182.836,186.832,189.082,190.081,194.581,198.577,203.077,207.073,210.574,212.824,213.823,216.82,224.821,227.818,234.316,237.313,240.814,243.811,246.061,248.311,249.31,255.808,259.804,264.304,268.3,270.55,271.549,275.545,280.045,284.545,287.542,291.538,295.039" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.78,0.5,0.39,0.28,0.25,0.55,0.28,0.5,0.33,0.5,0.33,0.78,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.33,0.89,0.33,0.72,0.33,0.39,0.33,0.25,0.25,0.55,0.72,0.44,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were defined as most informative genes (MIG´s). Gene expres-</text>
   <text y="498.061" x="62.362,65.863,68.365,72.865,77.365,79.615,82.09,86.59,89.092,91.927,94.924,98.92,101.917,105.913,110.413,114.409,118.405,121.906,124.156,126.631,131.131,135.127,137.629,144.127,148.123,152.119,156.619,158.869,161.344,165.844,170.344,172.846,175.348,182.35,186.346,188.848,191.098,193.573,197.569,202.069,206.569,208.819,211.294,214.795,219.295,223.795,226.792,231.292,235.792,238.294,240.796,247.798,251.794,254.296,256.546,259.021,262.018,266.014,269.515,274.015,278.515,283.015,287.515,291.511,294.508,298.009" svgx:width="0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.39,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.28,0.28,0.78,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.33,0.5,0.5,0.28,0.28,0.78,0.44,0.28,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sion differences between optimal and sub-optimal responders </text>
   <text y="509.059" x="62.362,66.862,71.362,75.358,78.355,80.434,84.934,87.013,91.513,95.509,99.505,102.502,104.581,108.577,113.077,117.577,119.656,122.653,127.153,131.653,135.649,138.151,140.653,145.153,149.653,153.649,156.151,158.23,162.226,166.726,170.722,173.224,177.724,181.225,183.727,187.228,189.307,193.807,197.308,199.81,204.31,208.81,210.889,213.886,218.386,222.886,226.882,231.382,235.882,238.384,240.886,245.386,247.465,250.966,255.466,258.463,260.965,267.463,271.459,274.456,278.452,280.531,287.029,291.025,294.022,298.018" svgx:width="0.5,0.5,0.44,0.33,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.33,0.5,0.5,0.44,0.5,0.5,0.28,0.28,0.5,0.25,0.39,0.5,0.33,0.28,0.72,0.44,0.33,0.44,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">over 1 year and functional analysis using Ingenuity software were </text>
   <text y="520.057" x="62.362,66.862,70.858,73.855,76.852,81.352,84.349,91.351,95.347,99.847" svgx:width="0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">performed.</text>
   <text y="531.055" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="531.055" x="100.585,105.589,109.585,114.085,118.081,122.581,125.083,129.583,131.833,136.81,140.806,143.308,147.808,152.308,154.81,157.06,162.037,166.537,170.533,173.53,177.526,181.522,186.022,188.524,190.774,195.751,198.748,203.248,208.324,212.824,217.324,220.321,222.571,227.548,232.048,235.045,237.295,242.272,246.772,250.768,253.27,255.772,259.768,264.268,266.77,270.271,272.521,277.498,281.998,286.498,290.998,294.994,297.991" svgx:width="0.56,0.44,0.5,0.44,0.5,0.28,0.5,0.25,0.55,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.5,0.44,0.33,0.44,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Seventy eight percent (n=52) of patients under </text>
   <text y="542.053" x="62.362,68.86,72.856,75.358,79.354,81.856,84.358,88.354,92.854,99.856,103.852,108.352,110.566,113.068,116.065,120.061,124.057,126.559,133.561,137.557,142.057,144.559,146.773,153.271,157.267,160.264,164.26,166.474,169.471,173.467,175.969,179.965,184.465,187.966,191.962,194.176,198.172,202.672,207.172,209.386,213.886,216.388,219.889,223.885,227.881,231.382,235.378,237.592,242.092,245.089,249.589,254.089,257.086,261.082,264.583,268.084,270.586,275.086,279.586,281.8,284.797,287.794,291.79,295.786,298.036" svgx:width="0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.33,0.33,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natalizumab treatment were relapse and disease progression free. </text>
   <text y="553.051" x="62.362,65.359,69.859,72.334,74.836,79.336,83.332,85.807,88.804,92.8,96.301,100.801,105.301,109.801,114.301,118.297,121.294,124.795,127.27,131.77,134.767,139.267,143.767,148.267,150.742,156.241,162.739,167.743,172.747,175.222,177.724,184.726,189.226,192.223,196.723,201.223,205.219,209.719,212.194,216.694,221.194,223.669,226.666,231.166,233.416,237.916,242.857,247.357,249.607,254.107,256.582,260.578,263.08,265.555,270.055,272.53,277.03,281.026,285.022,288.019,290.494,294.49,297.991" svgx:width="0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.44,0.28,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In the responders group EDSS improved by -0.2±0.1 at 1 year as </text>
   <text y="564.049" x="62.362,66.358,70.858,77.86,82.36,86.356,89.353,93.349,97.849,100.369,102.871,107.371,109.891,113.392,117.892,122.392,126.892,131.392,133.894,136.396,143.398,147.394,149.896,152.416,155.413,159.409,162.91,167.41,171.91,176.41,180.91,184.906,187.903,191.404,193.924,196.426,200.926,203.446,209.944,214.444,216.946,220.942,225.442,227.962,233.461,239.959,244.963,249.967,252.487,254.989,259.489,263.485,266.482,270.478,274.474,277.975,281.971,286.471,288.991,293.491,297.991" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.39,0.5,0.5,0.5,0.5,0.28,0.28,0.78,0.44,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.28,0.5,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">compared to suboptimal responders in which EDSS increased by </text>
   <text y="575.047" x="62.362,66.862,69.112,73.612,78.553,83.053,85.303,89.803,92.548,95.545,100.045,105.121,109.621,111.871,116.371,121.87,124.867,129.367,133.867,136.864,139.114,141.859,148.357,152.353,154.855,158.851,161.353,165.853,169.849,174.349,181.351,185.347,189.847,192.592,195.589,199.585,203.086,207.586,212.086,216.586,220.582,223.579,227.08,229.825,236.323,240.319,243.316,247.312,250.057,254.053,258.553,262.549,265.546,269.542,273.538,276.04,280.036,283.033,285.535,289.531,293.527,298.027" svgx:width="0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.61,0.33,0.5,0.5,0.33,0.25,0.25,0.72,0.44,0.28,0.44,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">0.7±0.1 (p=1.3E-10). Natalyzumab respoders were characterized </text>
   <text y="586.045" x="62.362,66.862,71.362,73.612,76.051,80.551,85.051,89.551,91.801,94.24,102.241,105.238,111.736,115.237,117.487,119.926,123.922,128.422,131.419,133.921,137.917,142.417,146.413,150.913,153.163,155.602,160.102,164.602,166.852,169.291,176.293,180.289,184.285,188.785,192.781,197.281,199.783,203.284,210.286,213.787,216.037,218.476,222.976,225.973,228.223,230.662,236.665,238.915,241.354,245.35,249.346,251.848,254.35,257.851,260.101,262.54,266.536,270.532,273.034,275.536,280.036,284.032,286.534,289.036,293.536,298.036" svgx:width="0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.89,0.33,0.72,0.39,0.25,0.55,0.44,0.5,0.33,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">by 508 MIGs enriched by mechanisms of B cells activation </text>
   <text y="597.043" x="62.362,64.864,69.364,73.36,75.862,80.362,84.862,87.364,91.864,96.364,98.812,104.815,107.263,111.259,115.255,117.757,120.259,123.76,126.208,130.708,134.704,139.204,143.2,145.702,150.202,154.702,161.704,165.7,170.2,172.702,175.15,178.147,182.647,187.723,192.223,194.473,198.973,204.472,207.469,211.969,216.469,219.466,221.716,224.164,229.168,232.165,236.665,243.163,245.611,250.615,253.117,257.617,262.117,266.113,268.615,271.117,275.617,280.117,282.565,285.067,289.567,292.015,298.018" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.61,0.33,0.5,0.5,0.33,0.25,0.25,0.56,0.33,0.5,0.72,0.25,0.56,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">including B cells development (p=8.7E-08), PI3K Signaling in B </text>
   <text y="608.041" x="62.362,64.864,69.364,76.366,80.866,85.366,89.866,93.862,98.362,100.864,104.86,108.361,110.944,113.941,118.441,123.517,128.017,130.267,134.767,140.266,143.263,147.763,152.263,155.26,157.51,160.093,164.089,168.589,173.089,175.672,181.675,187.678,193.681,196.264,199.765,202.267,206.767,211.267,215.263,217.765,220.267,224.767,229.267,231.85,234.847,239.347,244.423,248.923,251.173,255.673,261.172,264.169,268.669,273.169,276.166,278.416,280.999,286.003,290.503,295.003" svgx:width="0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.61,0.33,0.5,0.5,0.33,0.25,0.25,0.44,0.5,0.5,0.25,0.67,0.67,0.67,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.61,0.33,0.5,0.5,0.33,0.25,0.25,0.56,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lymphocytes (p=6.1E-06), and BCR signaling (p=3.4E-04). Sub-</text>
   <text y="619.039" x="62.362,66.862,71.362,73.864,76.366,83.368,87.364,89.866,92.017,95.014,99.01,102.511,107.011,111.511,116.011,120.511,124.507,127.504,131.005,133.156,139.654,143.65,146.647,150.643,152.794,157.294,159.796,162.631,165.628,169.624,172.621,176.617,181.117,183.268,185.77,190.27,192.421,196.921,200.917,205.417,209.413,211.564,215.56,220.06,224.56,227.557,231.553,235.054,238.555,241.057,245.557,250.057,252.208,256.708,259.705,261.856,266.356,270.856,275.356,277.507,282.007,286.003,290.503,294.499,298.0" svgx:width="0.5,0.5,0.28,0.28,0.78,0.44,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">optimal responders were differed in gene expression of 345 genes </text>
   <text y="630.037" x="62.362,65.359,69.859,74.935,77.815,82.315,84.565,89.065,93.565,96.445,100.945,105.445,108.163,112.834,115.831,118.333,122.329,125.83,128.332,131.329,133.579,136.459,139.456,143.956,146.458,150.454,153.451,157.447,160.948,163.45,165.952,170.452,174.952,177.454,181.369,183.619,186.499,189.001,193.501,196.003,199.504,202.384,206.884,209.881,214.381,217.378,219.88,222.382,226.378,229.879,232.759,239.257,243.253,246.754,249.634,253.63,256.132,259.633,264.133,267.013,271.009,275.509,278.506,281.008,285.004,289.504,293.5,298.0" svgx:width="0.33,0.5,0.56,0.25,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.25,0.61,0.33,0.28,0.44,0.39,0.28,0.33,0.25,0.25,0.33,0.5,0.28,0.44,0.33,0.44,0.39,0.28,0.28,0.5,0.5,0.28,0.5,0.25,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.39,0.25,0.72,0.44,0.39,0.25,0.44,0.28,0.39,0.5,0.25,0.44,0.5,0.33,0.28,0.44,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(p&lt; 0.05 by T-test). Interestingly, this profiles was also enriched </text>
   <text y="641.035" x="62.362,66.862,71.362,73.612,74.638,79.138,83.134,87.634,91.63,95.131,97.381,98.407,101.404,105.4,107.902,111.898,114.4,118.396,122.896,125.146,126.172,128.674,133.174,135.424,136.45,142.453,144.703,145.729,149.725,153.721,156.223,158.725,162.226,164.476,165.502,170.002,173.998,178.498,182.494,184.996,189.496,193.996,200.998,204.994,209.494,211.996,214.246,215.272,218.269,222.769,227.845,232.345,234.595,239.095,244.594,247.591,252.091,256.591,259.588,261.838,264.088,265.114,269.614,274.114,280.612,284.608,289.108,293.104,295.741,297.991" svgx:width="0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.56,0.5,0.25,0.5,0.61,0.33,0.5,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">by genes related to B cells development (p=2.8E-04), however, </text>
   <text y="652.033" x="62.362,66.862,70.858,74.359,78.355,82.855,85.285,89.785,94.285,96.715,100.711,105.211,112.213,116.713,119.215,123.211,125.713,129.709,132.211,136.711,139.141,143.641,146.143,148.978,151.975,155.971,158.968,162.964,167.464,169.966,172.396,176.896,180.892,183.394,187.894,194.392,198.388,202.888,205.318,209.314,213.814,220.816,225.316,229.816,234.316,238.312,242.812,245.314,248.815,251.065,253.495,258.499,262.999,267.499,270.496,274.996,279.496,281.998,284.5,291.502,295.498,298.0" svgx:width="0.5,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.28,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.39,0.25,0.25,0.56,0.5,0.5,0.33,0.5,0.5,0.28,0.28,0.78,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">based on completely different pathway components. Sub-optimal </text>
   <text y="663.031" x="62.362,65.359,69.355,72.856,77.356,81.856,86.356,90.856,94.852,97.849,101.35,103.969,110.467,114.463,117.46,121.456,124.075,128.071,132.571,136.567,139.564,143.56,147.556,150.058,154.054,157.051,159.553,163.549,167.545,172.045,174.664,179.164,183.664,186.283,190.279,194.275,196.777,199.279,203.779,207.775,210.277,212.779,217.279,221.779,224.398,228.898,231.895,234.514,237.016,244.018,251.02,255.52,260.02,264.52,269.02,271.522,276.022,280.522,285.022,287.524,290.026,294.526,298.027" svgx:width="0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">responders were characterized by activation of immunoglobulins </text>
   <text y="674.029" x="62.362,65.359,69.355,76.357,78.859,81.361,85.861,88.111,92.611,96.607,101.107,105.103,108.604,110.854,113.356,117.856,121.852,124.354,128.854,133.354,135.856,140.356,144.856,147.106,150.103,156.601,163.099,169.597,171.847,174.097,177.094,183.592,190.09,198.091,200.341,202.591,205.588,212.086,218.584,224.587,226.837,229.087,232.084,238.582,244.081,250.084,254.584,256.834,259.084,265.087,271.585,276.085,280.585" svgx:width="0.33,0.44,0.78,0.28,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.39,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.33,0.72,0.72,0.72,0.25,0.25,0.33,0.72,0.72,0.89,0.25,0.25,0.33,0.72,0.72,0.67,0.25,0.25,0.33,0.72,0.61,0.67,0.5,0.25,0.25,0.67,0.72,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">family genes including IGHD, IGHM, IGKC, IGLC1, CD43.</text>
   <text y="685.027" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="685.027" x="114.022,120.52,123.022,125.173,129.673,134.173,138.169,140.32,144.82,148.816,152.812,155.809,157.96,162.46,165.457,167.608,174.106,178.102,180.604,184.6,187.102,189.604,193.6,198.1,205.102,209.098,213.598,215.749,218.251,221.248,225.244,229.24,231.742,238.744,242.74,247.24,249.742,251.893,256.393,260.389,262.891,265.393,269.389,273.889,276.391,279.892,282.043,288.541,291.043,293.545,298.045" svgx:width="0.72,0.28,0.25,0.5,0.5,0.44,0.25,0.5,0.44,0.44,0.33,0.25,0.5,0.33,0.25,0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">At one year of Natalizumab treatment patients with </text>
   <text y="696.025" x="62.362,65.863,70.363,74.863,77.86,82.36,86.86,89.362,91.864,98.866,102.862,105.364,107.614,109.639,113.635,116.137,118.639,123.139,125.641,129.637,133.633,136.135,138.385,140.41,143.407,147.403,150.904,155.404,159.904,164.404,167.905,171.901,174.151,176.176,180.676,184.672,191.674,196.174,200.674,204.175,206.677,209.674,213.67,216.172,220.168,224.668,226.918,228.943,233.443,237.943,241.939,244.756,247.753,251.749,256.249,260.749,263.746,267.742,271.243,274.744,277.246,281.746,286.246,288.496,290.521,295.021,298.018" svgx:width="0.39,0.5,0.5,0.33,0.5,0.5,0.28,0.28,0.78,0.44,0.28,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.44,0.33,0.33,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sub-optimal clinical response demonstrated over-expression of </text>
   <text y="707.023" x="62.362,65.863,70.363,74.359,78.355,80.857,83.854,86.356,90.352,92.602,93.511,97.012,101.512,106.012,109.513,113.509,116.011,118.261,119.17,123.67,126.667,128.917,129.826,132.328,139.33,146.332,150.832,155.332,159.832,164.332,166.834,171.334,175.834,180.334,182.836,185.338,189.838,193.339,195.589,196.498,199.495,203.491,205.993,209.989,212.491,216.487,220.987,223.237,224.146,228.646,232.642,237.142,241.138,244.639,246.889,249.139,249.886,255.385,259.885,263.881,267.382,271.378,273.628,274.537,277.534,281.53,285.031,289.531,292.033,294.535,298.036" svgx:width="0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.39,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">specific subset of immunoglobulins related genes. These results </text>
   <text y="718.021" x="62.362,66.862,70.858,75.358,79.354,81.874,85.87,88.372,90.874,95.374,97.876,101.872,105.868,108.37,110.89,113.392,120.394,124.894,127.396,129.898,133.894,137.89,140.392,142.894,147.394,151.894,155.395,157.915,160.417,164.917,168.913,171.415,173.935,180.937,184.933,189.433,191.953,194.455,198.451,202.447,206.947,209.467,211.969,216.469,218.989,223.489,227.485,229.987,232.489,236.485,239.482,242.002,249.004,253.0,257.5,261.496,265.996,269.992,276.994,280.99,285.49,287.992,290.512,295.012,298.009" svgx:width="0.5,0.44,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.44,0.28,0.25,0.78,0.44,0.5,0.25,0.28,0.44,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.78,0.44,0.5,0.44,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">have clinical implications that may lead to better management of </text>
   <text y="729.019" x="62.362,68.86,72.856,75.358,79.354,81.856,84.358,88.354,92.854,99.856,103.852,108.352,110.602,113.104,116.101,120.097,124.093,126.595,130.591,135.091,137.341,143.344,149.347,157.348,162.352,164.602,169.102,173.098,175.6,178.102,182.098,186.598,189.1,192.601" svgx:width="0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natalizumab treated RRMS patients.</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 111.160 L355.010 111.160 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 649.160 L341.760 649.160 "/>
  <g begin="text">
   <text y="76.959" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P971</text>
   <text y="87.957" x="310.016,316.514,319.016,322.013,325.01,329.006,333.002,336.998,342.002,344.999,347.501,352.001,354.503,356.753,360.749,363.746,366.743,370.739,374.735,377.732,381.233,383.483,387.983,390.98,393.23,396.227,398.729,403.733,408.233,412.733,415.235,417.737,425.234,429.734,434.738,436.988,441.488,446.492,451.496,453.746,457.742,462.242,467.246,471.746,476.246,480.746,485.75,489.746,491.996,497.0,502.004,506.504,511.508" svgx:width="0.72,0.28,0.33,0.33,0.44,0.44,0.44,0.56,0.33,0.28,0.5,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.33,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56,0.25,0.5,0.56,0.56,0.25,0.44,0.5,0.56,0.5,0.5,0.5,0.56,0.44,0.25,0.56,0.56,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Differential effects of fingolimod and copaxone upon </text>
   <text y="98.955" x="310.016,315.515,320.015,324.515,330.014,334.514,339.644,341.894,345.89,349.886,354.386,359.39,361.892,366.392,369.389,373.889,377.885,382.385,384.635,390.638,393.635,397.631,401.627,404.129,406.631,410.132,412.382,414.884,419.888,422.138,430.634" svgx:width="0.61,0.5,0.5,0.61,0.5,0.57,0.25,0.44,0.44,0.5,0.56,0.28,0.5,0.33,0.5,0.44,0.5,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.56,0.25,0.94,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">FoxP3+ regulatory B-cells in MS</text>
   <text y="109.953" x="310.016,316.019,318.269,322.769,326.765,329.015,335.513,340.013,344.513,347.51,351.506" svgx:width="0.67,0.25,0.5,0.44,0.25,0.72,0.5,0.5,0.33,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">C de Andres</text>
   <text y="107.439" x="355.006" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="357.931,360.181,362.431,368.434,370.684,377.182,379.684,384.184,388.684,392.185" svgx:width="0.25,0.25,0.67,0.25,0.72,0.28,0.5,0.5,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Alonso</text>
   <text y="107.439" x="396.685" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="109.959" x="399.61,401.86,404.11,409.609,411.859,416.863,420.859,423.856,428.356,432.352,436.852,441.352,445.348,449.344,451.594,457.597,460.594,465.094" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.33,0.5,0.44,0.5,0.5,0.44,0.44,0.25,0.67,0.33,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Fernández Cruz</text>
   <text y="107.439" x="469.089" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="109.959" x="472.014,474.264,476.514,482.013,484.263,489.267,493.263,496.26,500.76,504.756,509.256,513.756,517.752,521.748" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.33,0.5,0.44,0.5,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Fernández </text>
   <text y="120.957" x="310.014,315.018,319.014,322.011,326.007,330.507,334.503" svgx:width="0.56,0.44,0.33,0.44,0.5,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Paredes</text>
   <text y="118.439" x="338.005" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="120.959" x="340.93,343.18,345.43,350.434,352.684,357.688,361.684,366.184,370.18,374.68,378.676,382.672,384.922,390.925,394.921,401.923,406.423" svgx:width="0.25,0.25,0.56,0.25,0.56,0.44,0.5,0.44,0.5,0.44,0.44,0.25,0.67,0.44,0.78,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Sánchez Ramón</text>
   <text y="118.439" x="410.922" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="129.437" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="131.959" x="312.941,319.439,322.94,326.936,331.436,335.936,339.437,341.939,346.439,348.689,356.186,360.686,364.187,368.687,373.187,377.687,382.187,384.437,386.687,392.69,396.686,401.186,404.687,409.187,411.689,416.189,420.689,424.685,426.935,429.185,436.682,441.182,445.682,449.183,451.685,456.185,458.435,460.685,465.185,469.685,474.185,476.687,481.187,483.437" svgx:width="0.72,0.39,0.44,0.5,0.5,0.39,0.28,0.5,0.25,0.83,0.5,0.39,0.5,0.5,0.5,0.5,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.5,0.5,0.39,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Gregorio Marañón, Neurology, Madrid, Spain, </text>
   <text y="129.439" x="485.686" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="131.959" x="488.611,495.109,498.61,502.606,507.106,511.606,515.107,517.609,522.109" svgx:width="0.72,0.39,0.44,0.5,0.5,0.39,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Gregorio </text>
   <text y="142.957" x="310.015,317.512,322.012,325.513,330.013,334.513,339.013,343.513,345.763,348.013,351.01,357.508,364.006,368.506,373.006,377.506,380.008,384.508,389.008,393.004,395.254,397.504,405.001,409.501,414.001,417.502,420.004,424.504,426.754,429.004,433.504,438.004,442.504,445.006,449.506,451.756" svgx:width="0.83,0.5,0.39,0.5,0.5,0.5,0.5,0.25,0.25,0.33,0.72,0.72,0.5,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.5,0.5,0.39,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Marañón, Immunology, Madrid, Spain, </text>
   <text y="140.439" x="454.006" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="142.959" x="456.931,463.429,466.93,470.926,475.426,479.926,483.427,485.929,490.429,492.679,500.176,504.676,508.177,512.677,517.177,521.677,526.177,528.427" svgx:width="0.72,0.39,0.44,0.5,0.5,0.39,0.28,0.5,0.25,0.83,0.5,0.39,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Gregorio Marañón, </text>
   <text y="153.957" x="310.015,317.512,322.012,326.512,330.013,332.515,337.015,339.265,341.515,346.015,350.515,355.015,357.517,362.017,364.267" svgx:width="0.83,0.5,0.5,0.39,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Madrid, Spain, </text>
   <text y="151.439" x="366.518" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="153.959" x="369.443,375.941,380.441,383.942,388.442,390.944,393.446,397.946,400.448,402.698,408.701,411.203,413.705,418.205,420.707,424.703,429.203,431.453,435.953,439.949,442.199,446.699,451.199,455.699,457.949,463.952,468.452,471.953,474.455,478.955,482.456,484.706,486.956,489.953,494.453,500.951,505.451,509.951,514.451,516.953,521.453,525.953,529.949,532.199" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.25,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.67,0.5,0.39,0.28,0.5,0.39,0.25,0.25,0.33,0.5,0.72,0.5,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hospital Clínico de San Carlos, Inmunology, </text>
   <text y="164.957" x="310.016,317.513,322.013,326.513,330.014,332.516,337.016,339.266,341.516,346.016,350.516,355.016,357.518,362.018,364.268" svgx:width="0.83,0.5,0.5,0.39,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Madrid, Spain, </text>
   <text y="162.439" x="366.518" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="164.959" x="369.443,375.941,380.441,383.942,388.442,390.944,393.446,397.946,400.448,402.698,408.701,411.203,413.705,418.205,420.707,424.703,429.203,431.453,435.953,439.949,442.199,446.699,451.199,455.699,457.949,463.952,468.452,471.953,474.455,478.955,482.456,484.706,486.956,489.953,496.451,502.949,507.449,511.949,516.449,518.951,523.451,527.447,529.697" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.25,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.67,0.5,0.39,0.28,0.5,0.39,0.25,0.25,0.33,0.72,0.72,0.5,0.5,0.5,0.28,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hospital Clínico de San Carlos, Immunolgy, </text>
   <text y="175.957" x="310.016,317.513,322.013,326.513,330.014,332.516,337.016,339.266,341.516,346.016,350.516,355.016,357.518" svgx:width="0.83,0.5,0.5,0.39,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Madrid, Spain</text>
   <text y="202.957" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="202.957" x="362.837,368.84,371.315,375.311,379.307,381.809,384.311,387.812,390.287,394.283,397.28,401.276,403.751,406.253,413.255,417.755,420.257,422.759,426.755,430.751,433.253,437.249,441.749,444.224,446.726,451.226,453.701,456.203,460.703,464.699,467.174,469.676,476.678,483.68,488.18,492.68,496.676,499.151,503.651,507.647,510.149,514.649,519.149,523.649,527.645,532.145,536.141,539.642,542.144,545.645" svgx:width="0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.33,0.44,0.25,0.28,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">B cells are implicated in the immune pathogenesis </text>
   <text y="213.955" x="310.016,314.516,317.513,320.285,327.287,331.787,334.289,336.791,339.293,343.793,346.295,350.291,353.063,356.564,360.56,363.062,367.058,370.055,374.555,378.056,380.558,384.059,386.831,389.828,397.829,402.833,405.83,408.602,413.102,417.602,420.374,423.875,427.871,431.867,434.864,438.86,441.362,443.864,448.364,452.864,455.636,459.632,464.132,466.634,469.136,473.636,478.136,482.636,485.138,489.134,492.635,495.407,499.403,503.903,508.403,511.175,515.171,519.671,522.173,526.673,531.173,533.675,538.175,542.171,545.672" svgx:width="0.5,0.33,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.5,0.5,0.25,0.39,0.44,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of multiple sclerosis (MS) by secreting antibodies and cytokines </text>
   <text y="224.953" x="310.016,314.012,317.513,319.826,326.324,330.32,332.822,335.324,337.628,341.624,345.125,347.438,351.938,356.438,358.751,361.253,365.753,369.749,372.251,375.248,377.561,381.557,384.392,387.389,389.891,393.887,396.389,400.385,404.885,407.387,409.691,413.687,418.187,420.689,423.191,427.691,431.687,436.187,438.5,443.0,445.997,449.993,453.494,457.49,461.99,464.492,468.488,470.99,473.492,477.992,482.492,484.742" svgx:width="0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.44,0.33,0.33,0.28,0.44,0.28,0.44,0.5,0.28,0.25,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">as well as by their efficient antigen presentation. </text>
   <text y="224.953" x="487.046,492.545,495.047,500.051,504.551,509.051,511.553,514.055,521.552,526.052,531.056" svgx:width="0.61,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Fingolimod </text>
   <text y="224.953" x="533.369,535.871,539.372,541.685,545.681" svgx:width="0.28,0.39,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">is a </text>
   <text y="235.951" x="310.025,317.027,321.527,324.029,328.025,332.021,336.521,339.023,343.019,344.846,348.842,353.342,357.338,364.34,366.842,370.838,374.834,377.336,379.838,384.338,386.165,389.162,393.158,395.66,399.656,402.158,406.154,410.654,412.481,414.983,419.483,421.31,424.811,429.311,433.811,436.313,440.813,445.313,449.813,453.314,455.816,460.316,464.312,466.562,468.389,472.385,476.381,480.881,484.382,488.378,491.879,493.706,496.208,500.708,503.21,507.206,510.203,514.703,518.699,521.201,523.703,527.699,531.695,534.197,536.699,541.199,545.699" svgx:width="0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.25,0.44,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.39,0.5,0.5,0.28,0.5,0.5,0.5,0.39,0.28,0.5,0.44,0.25,0.25,0.44,0.44,0.5,0.39,0.44,0.39,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">molecule chemically related to sphingosine, causes internalization </text>
   <text y="246.949" x="310.025,314.525,317.522,319.772,323.012,326.513,331.013,335.513,338.015,342.515,347.015,351.515,355.016,357.518,362.018,366.014,369.011,373.511,376.508,381.008,385.508,390.008,393.509,398.009,402.509,406.505,409.007,413.003,415.253,418.484,421.481,426.485,430.985,435.989,438.986,441.236,444.476,447.473,451.469,455.465,459.461,463.961,466.463,470.963,473.96,477.461,479.711,482.942,487.442,491.942,494.192,497.432,499.934,504.434,511.436,515.936,520.436,524.936,528.932,533.432,535.934,539.93,543.431,545.681" svgx:width="0.5,0.33,0.25,0.55,0.39,0.5,0.5,0.28,0.5,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.5,0.33,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.28,0.44,0.25,0.55,0.33,0.56,0.5,0.56,0.33,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of sphingosine-1-phosphate (S1P) receptors on lymphocytes, </text>
   <text y="257.947" x="310.025,312.527,317.027,321.023,324.02,328.016,332.516,337.016,339.266,341.66,346.16,348.662,353.162,357.158,361.658,364.16,368.66,373.16,375.41,377.804,380.306,384.806,388.802,391.304,394.301,396.551,398.945,402.941,407.441,410.438,414.434,417.935,421.436,423.686,426.08,429.077,432.074,436.574,443.576,445.826,448.22,450.722,455.222,462.224,466.724,471.224,473.474,475.868,480.368,484.868,489.368,493.364,496.865,499.115,501.509,505.505,510.005,514.505,516.755,519.149,521.651,526.151,530.651,537.653,542.153,545.654" svgx:width="0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.44,0.5,0.33,0.44,0.39,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.78,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.78,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">thereby blocking their egress from lymph nodes and thymus </text>
   <text y="268.945" x="310.025,312.527,317.027,321.023,324.02,328.016,332.516,337.016,339.095,342.092,346.088,350.588,355.088,359.084,361.586,366.086,370.586,372.665,375.167,379.667,383.663,387.164,391.16,393.239,397.235,401.231,403.733,406.235,409.736,411.815,414.317,418.817,420.896,423.398,427.898,431.894,433.973,438.473,442.469,445.466,447.968,452.468,456.968,460.964,463.961,468.461,470.54,474.536,479.036,483.536,485.615,488.117,492.617,496.613,499.115,502.112,504.191,507.188,511.184,515.18,518.177,522.677,525.179,527.681,534.683,538.679,543.179,545.681" svgx:width="0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.33,0.44,0.44,0.33,0.5,0.28,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">thereby reducing these cells in the periphery and their recruitment </text>
   <text y="279.943" x="310.025,312.527,317.027,319.529,324.029,326.279,327.881,331.382,333.884,336.386,340.382,343.883,346.133,347.735,352.235,355.232,357.482,359.084,361.586,366.086,369.083,371.585,375.581,382.583,389.585,393.581,396.083,398.585,403.085,407.585,409.835" svgx:width="0.28,0.5,0.28,0.5,0.25,0.55,0.39,0.28,0.28,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">into sites of inflammation. </text>
   <text y="279.943" x="413.705,420.707,423.209,427.709,430.706,433.208,437.204,441.704,449.201,453.197,457.031,459.281,460.883,465.383,469.379,473.375,476.372,480.872,483.869,487.865,490.115,491.717,494.714,501.716" svgx:width="0.78,0.28,0.5,0.33,0.28,0.44,0.5,0.83,0.44,0.44,0.25,0.55,0.5,0.44,0.44,0.33,0.5,0.33,0.44,0.25,0.55,0.33,0.78,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Glatiramer acetate (GA</text>
   <text y="279.943" x="508.214,511.211,513.461,515.711,517.313,519.815,523.316,525.566,527.168,531.164,535.664,542.666" svgx:width="0.33,0.25,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">), is com-</text>
   <text y="290.941" x="310.025,314.525,319.025,322.526,326.522,331.022,333.767,338.267,341.264,344.009,347.006,351.506,356.006,359.003,361.748,365.744,372.746,375.248,379.748,384.248,386.993,390.989,394.985,397.487,401.987,405.488,408.233,411.23,416.729,419.726,424.226,426.728,431.228,433.73,437.726,444.728,447.23,451.226,453.971,457.967,461.963,464.465,468.965,471.215,473.96,479.459,482.456,486.452,488.954,492.95,497.45,499.952,504.452,508.448,510.698,513.443,518.942,521.939,524.441,528.941,532.442,534.944,539.444,543.44,545.69" svgx:width="0.5,0.5,0.39,0.44,0.5,0.25,0.5,0.33,0.25,0.33,0.5,0.5,0.33,0.25,0.44,0.78,0.28,0.5,0.5,0.25,0.44,0.44,0.28,0.5,0.39,0.25,0.33,0.61,0.33,0.5,0.28,0.5,0.28,0.44,0.78,0.28,0.44,0.25,0.44,0.44,0.28,0.5,0.25,0.25,0.61,0.33,0.44,0.28,0.44,0.5,0.28,0.5,0.44,0.25,0.25,0.61,0.33,0.28,0.5,0.39,0.28,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">posed of four amino acids (L-glutamic acid, L-alanine, L-lysine, </text>
   <text y="301.939" x="310.025,314.021,318.521,323.021,325.271,327.134,332.633,335.63,338.132,342.632,345.629,350.129,353.63,356.132,360.632,364.628,367.625,369.875,372.125,373.988,378.992,381.494,385.994,390.494,392.996,396.992,400.493,402.743,404.606,408.107,412.607,417.107,423.605,427.601,432.101,434.351,436.214,438.716,443.216,447.212,449.714,451.964,453.827,459.83,462.08,463.943,467.939,471.935,474.437,476.939,480.44,482.69,484.553,487.55,490.547,495.047,502.049,504.299,506.162,512.165,516.665,521.165,525.161,529.661,534.161,538.661,542.657" svgx:width="0.44,0.5,0.5,0.25,0.55,0.61,0.33,0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.44,0.33,0.25,0.25,0.55,0.56,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.67,0.5,0.5,0.44,0.5,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and L-tyrosine). Studies showed that B cells from Copaxone-</text>
   <text y="312.937" x="310.025,312.527,315.524,319.52,323.516,326.018,330.014,334.514,336.764,337.601,344.603,347.105,351.101,355.097,357.347,358.184,360.686,365.186,369.182,372.179,376.175,380.171,383.672,387.668,392.168,394.418,395.255,399.755,402.752,407.252,411.752,416.252,420.248,422.75,425.252,429.752,434.252,436.502,437.339,441.839,444.836,447.086,447.923,450.92,456.419,459.416,463.916,468.416,470.666,471.503,475.499,479.999,484.499,486.749,487.586,490.583,494.579,499.079,503.579,507.575,511.571,516.071,518.321,519.158,523.154,527.654,532.154,535.151,539.147,542.648" svgx:width="0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.78,0.28,0.44,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.61,0.33,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treated mice increased production of IL-10 and reduced expres-</text>
   <text y="323.935" x="310.025,313.526,316.028,320.528,325.028,327.278,331.778,334.775,337.025,343.028,349.526,354.026,358.526,360.776,364.772,369.272,373.772,376.022,382.025,388.523,393.023,397.523" svgx:width="0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sion of CD80 and CD86.</text>
   <text y="334.933" x="310.025,317.027,322.031,325.028,329.024,333.02,336.017,338.519,343.019,347.015,350.516,353.513" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="334.933" x="354.935,359.804,364.304,365.726,369.722,373.223,376.724,380.72,384.221,385.643,388.145,392.645,394.067,398.567,403.067,404.489,410.492,416.495,424.496,429.5,430.922,435.422,439.418,441.92,444.422,448.418,452.918,455.42,458.921,460.343,462.845,465.842,469.838,473.834,476.336,480.332,484.832,486.254,492.752,495.254,497.756,502.256,503.678,508.682,511.184,515.684,520.184,524.684,527.186,529.688,536.69,541.19,545.69" svgx:width="0.61,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To asses in 13 RRMS patients treated with Fingolimod </text>
   <text y="345.931" x="310.025,314.021,318.521,323.021,325.19,329.69,334.19,336.359,342.362,348.365,356.366,361.37,363.539,366.041,369.038,373.034,377.03,379.532,383.528,388.028,390.197,396.695,399.197,401.699,406.199,408.368,414.371,418.871,423.371,427.367,431.867,436.367,440.867,444.863,447.032,449.534,452.531,454.7,457.202,461.702,465.698,468.695,472.691,474.86,477.362,480.863,483.032,487.028,491.528,496.028,498.197,502.697,505.199,508.034,511.031,515.027,518.024,522.02,526.52,530.516,534.512,536.681,541.181,545.681" svgx:width="0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.67,0.5,0.5,0.44,0.5,0.5,0.5,0.44,0.25,0.28,0.33,0.25,0.28,0.5,0.44,0.33,0.44,0.25,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 13 RRMS treated with Copaxone if there is any difference on </text>
   <text y="356.929" x="310.025,312.527,317.027,321.023,323.273,324.443,328.943,331.94,336.44,340.94,345.44,348.437,350.939,353.441,357.941,362.441,364.691,365.861,370.361,373.358,375.608,376.778,380.774,383.276,386.273,390.269,394.769,397.271,401.267,403.769,406.271,410.771,415.271,417.521,418.691,424.694,426.944,428.114,432.11,436.106,438.608,441.11,444.611,446.861,448.031,451.532,456.032,460.532,464.033,468.029,470.531,474.032,476.282,477.452,479.954,484.454,486.704,487.874,490.871,494.867,497.369,501.365,503.867,506.369,510.869,515.369,517.619,518.789,521.291,525.791,528.041,529.211,531.713,536.213,540.209,542.711,545.708" svgx:width="0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.33,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the proportion of circulating B cells subsets in relation to their </text>
   <text y="367.927" x="310.025,312.527,315.524,319.52,323.516,326.018,333.02,337.016,341.516,344.018" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment.</text>
   <text y="378.925" x="310.025,318.521,322.517,325.514,330.518,335.018,340.022,343.523,346.52" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="378.925" x="349.256,357.032,361.028,363.764,367.76,372.26,376.256,378.758,383.258,387.254,391.25,395.75,398.486,402.986,407.486,410.222,413.219,415.721,420.221,426.719,429.455,433.451,437.951,440.453,444.953,451.955,455.951,458.453,461.45,465.95,468.686,471.188,475.688,479.684,482.42,486.92,489.917,494.417,498.917,503.417,506.414,508.916,511.418,515.918,520.418,523.154,527.654,530.651,533.387,537.383,539.885,542.684" svgx:width="0.94,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.28,0.5,0.72,0.25,0.44,0.5,0.28,0.5,0.78,0.44,0.28,0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.28,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We analyzed by flow cytometry the proportion of cir-</text>
   <text y="389.923" x="310.025,314.021,318.521,321.023,325.019,327.521,330.023,334.523,339.023,341.273,345.737,351.74,353.99,358.454,362.45,366.446,368.948,371.45,373.7,378.164,382.664,387.164,391.16,395.66,400.16,402.662,407.162,411.662,415.658,418.16,420.41,424.874,427.376,431.876,434.378,438.374,440.876,443.126,447.59,453.593,460.091,464.591,469.091,474.167,476.417,478.667,483.131,489.134,495.632,500.132,504.632,509.708,514.712,519.212,523.712,525.962,528.212,532.676,536.672,541.172,545.672" svgx:width="0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.28,0.44,0.28,0.25,0.55,0.67,0.72,0.5,0.5,0.56,0.25,0.25,0.55,0.67,0.72,0.5,0.5,0.56,0.56,0.5,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">culating B cell phenotype; total CD19+, CD19+Fox, and </text>
   <text y="400.921" x="310.025,316.028,322.526,327.026,331.526,336.602,342.605,349.103,353.603,358.103,363.179,368.183,372.683,377.183,379.289,381.791,386.291,388.397,390.899,395.399,399.395,401.492,407.495,413.498,421.499,426.503,428.609,433.109,437.105,439.607,442.109,446.105,450.605,453.107,456.608,458.714,463.214,467.21,470.207,474.707,477.704,481.7,483.806,487.802,492.302,496.802,498.908,502.904,505.901,508.403,512.399,515.396,517.493,521.489,523.991,526.097,530.597,532.703,536.699,541.199,545.699" svgx:width="0.67,0.72,0.5,0.5,0.56,0.67,0.72,0.5,0.5,0.56,0.56,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.44,0.28,0.25,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD19+CD25+Fox in the RRMS patients before and after at 3 and </text>
   <text y="411.919" x="310.025,314.525,317.522,324.524,329.024,333.524,336.026,340.526,344.027,346.277,350.777,353.774,356.024,361.028,363.53,368.03,372.53,377.03,379.532,382.034,389.036,393.536,398.036,400.286,404.282,408.782,413.282,415.532,422.03,424.532,428.528,431.03,433.532,436.529,440.525,447.527,451.523,454.52,456.77,460.766,464.762,468.758,471.26,475.256,477.758,481.754,484.004,486.506,489.503,493.499,497.495,499.997,506.999,510.995,515.495,517.997" svgx:width="0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.5,0.33,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.28,0.44,0.28,0.28,0.33,0.44,0.78,0.44,0.33,0.25,0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">6-months of Fingolimod and Glatiramer acetate treatment.</text>
   <text y="422.917" x="310.025,316.523,320.519,324.02,329.024,331.526,334.523,338.024,341.021" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="422.917" x="343.046,348.545,353.045,357.041,359.057,361.559,366.059,368.561,372.557,375.059,377.084,383.087,385.103,387.605,392.105,399.107,403.607,408.107,412.607,416.603,421.103,423.605,427.601,431.102,433.118,436.619,439.121,443.621,448.121,450.623,453.62,456.122,460.118,464.114,468.614,471.116,473.618,478.118,480.134,484.634,488.63,492.626,495.623,499.619,503.615,507.116,511.112,515.612,517.628,521.624,524.126,526.142,530.642,532.667,536.663,541.163,545.663" svgx:width="0.61,0.5,0.44,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.67,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.44,0.28,0.25,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The total B lymphocytes significantly decreased at 3 and </text>
   <text y="433.915" x="310.025,314.525,317.522,324.524,329.024,333.524,336.026,340.526,344.027,346.277,349.508,354.008,359.084,363.584,365.834,370.334,374.834,377.084,380.315,384.311,388.811,393.311,395.561,398.792,403.292,405.542,410.042,414.542,416.792,419.042,422.273,425.27,429.266,432.767,437.267,441.263,445.259,447.761,450.263,454.763,458.759,461.261,465.761,468.011,471.242,474.239,478.739,481.736,483.986,487.217,490.214,492.716,497.216,501.716,506.216,508.718,511.22,518.222,522.722,527.222,529.472,532.703,536.699,541.199,545.699" svgx:width="0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">6-months p=0.05 and 0.03, respectively for fingolimod and </text>
   <text y="444.913" x="310.025,314.525,319.601,324.101,326.351,330.851,335.351,337.601,341.831,345.827,350.327,354.827,357.077,361.307,365.807,368.057,372.557,377.057,379.307,381.557,385.787,388.784,392.78,396.281,400.781,404.777,408.773,411.275,413.777,418.277,422.273,424.775,429.275,431.525,435.755,438.752,443.252,446.249,448.499,452.729,458.732,463.232,467.732,471.728,476.228,480.728,485.228,489.224,491.474,493.724,497.954,503.957,508.457,510.707,514.937,518.933,523.433,527.933,530.435,533.432,537.428,540.929,543.431,545.681" svgx:width="0.5,0.56,0.5,0.25,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.67,0.5,0.5,0.44,0.5,0.5,0.5,0.44,0.25,0.25,0.55,0.67,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">p=0.02 and 0.05, respectively for Copaxone. By contrast, </text>
   <text y="455.911" x="310.025,315.029,317.531,322.031,326.531,331.031,333.533,336.035,343.037,347.537,352.037,354.314,357.815,362.315,366.815,373.313,377.309,381.809,384.086,387.587,390.089,394.589,399.089,401.591,404.588,407.09,411.086,415.082,419.582,422.084,424.586,429.086,431.363,433.865,438.365,442.361,445.358,449.354,453.35,456.851,460.847,465.347,467.624,470.621,474.617,479.117,483.617,486.119,490.115,492.617,497.117,500.114,504.614,506.891,512.894,515.171,517.673,522.173,529.175,533.675,538.175,542.675" svgx:width="0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.67,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fingolimod showed significantly increased regulatory B lympho-</text>
   <text y="466.909" x="310.025,314.021,318.521,321.023,325.019,328.52,330.554,333.551,339.554,342.551,346.547,351.047,354.044,356.078,360.074,364.574,369.074,372.071,376.067,379.568,383.069,385.571,390.071,394.571,396.605,399.107,403.607,407.603,409.637,414.137,418.637,422.633,425.135,429.131,433.127,436.124,438.158,440.66,443.657,447.653,452.153,455.654,459.65,462.647,465.149,469.649,472.151,474.653,479.153,483.653,485.687,488.684,492.68,496.676,499.178,503.678,506.675,508.709,512.705,516.206,519.707,524.207,528.203,530.705,534.701,537.203,541.199,545.699" svgx:width="0.44,0.5,0.28,0.44,0.39,0.25,0.33,0.67,0.33,0.44,0.5,0.33,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.28,0.33,0.44,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cytes (Breg) expressing the nuclear transcription factor associated </text>
   <text y="477.907" x="310.025,316.523,319.025,321.527,326.027,328.538,332.039,336.539,341.039,345.539,348.536,352.532,356.033,359.534,362.036,366.536,370.532,373.043,377.039,381.035,383.537,386.039,390.539,393.041,395.543,400.043,402.554,407.558,412.058,416.558,421.562,426.062,431.138,433.649,437.645,440.147,442.658,447.158,449.669,453.665,458.165,462.665,465.176,469.676,472.673,479.675,484.175,488.675,491.177,495.677,499.178,501.689,508.187,510.689,513.191,517.691,520.202,523.199,527.195,530.696,535.196,539.192,543.188,545.69" svgx:width="0.72,0.28,0.28,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.56,0.5,0.5,0.56,0.5,0.56,0.25,0.44,0.28,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with suppressive activity FoxP3+ at 3 and 6-months with respect </text>
   <text y="488.905" x="310.025,312.527,317.027,319.277,320.411,324.911,328.907,332.408,336.404,338.906,341.408,345.908,349.904,352.154,353.288,356.285,360.785,365.861,370.361,372.611,377.111,381.611,383.861,384.995,388.991,393.491,397.991,400.241,401.375,405.875,408.125,412.625,417.125,420.122,422.372,425.261,431.264,433.514,434.648,437.15,440.147,444.143,448.643,453.143,455.393,456.527,459.029,463.529,465.779,466.913,471.413,473.915,478.415,482.915,486.911,489.908,492.158,493.292,497.792,500.789,505.289,509.789,514.289,517.286,519.788,522.29,526.79,531.29,534.791,537.041,538.175,542.675,545.672" svgx:width="0.28,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.72,0.25,0.55,0.28,0.33,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to baseline (p=0.02 and 0.01). A trend to higher proportions of </text>
   <text y="499.903" x="310.025,316.028,322.526,327.026,331.526,336.602,342.605,349.103,353.603,358.103,363.179,368.183,372.683,377.183,382.187,386.687,391.763,394.013,395.039,401.537,405.533,409.034,411.284,412.31,416.306,418.808,422.309,426.809,429.059,430.085,434.081,438.581,443.081,447.077,450.074,454.07,458.57,461.072,463.322,464.348,468.344,470.846,473.096,474.122,478.622,481.619,488.621,493.121,497.621,500.123,504.623,506.873,507.899,512.399,515.396,517.646,518.672,521.669,524.171,528.671,533.171,537.671,540.173,542.675" svgx:width="0.67,0.72,0.5,0.5,0.56,0.67,0.72,0.5,0.5,0.56,0.56,0.5,0.5,0.56,0.5,0.56,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.28,0.39,0.5,0.25,0.55,0.44,0.5,0.5,0.44,0.33,0.44,0.5,0.28,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD19+CD25+FoxP3+ was also apparent at 3-month of fingoli-</text>
   <text y="510.901" x="310.025,317.027,321.527,326.027,328.754,331.751,336.251,341.327,345.827,348.077,352.577,357.077,360.074,362.324,364.889,370.388,374.888,378.884,381.611,387.614,392.114,396.614,400.61,405.11,409.61,414.11,418.106,420.833,425.333,427.835,432.335,435.062,439.562,444.062,446.564,449.291,452.792,457.292,461.792,468.29,471.017,475.013,479.513,484.013,486.74,490.736,495.236,499.232,503.732,508.232,512.228,515.729,518.456,520.958,525.458,528.185,534.188,537.185,541.181,545.681" svgx:width="0.78,0.5,0.5,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.67,0.5,0.5,0.44,0.5,0.5,0.5,0.44,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.39,0.5,0.5,0.72,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.67,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mod (p=0.06). The Copaxone did not show any changes in Breg </text>
   <text y="521.899" x="310.025,314.021,317.018,319.52,323.516,326.513,328.763,330.896,333.398,337.898,341.894,344.891,348.887,353.387,357.302,359.552,361.802,363.935,368.939,371.936,375.932,378.434,380.936,387.938,390.44,394.94,398.936,401.933,406.433,408.683,410.816,415.316,419.312,421.814,425.81,428.06,430.193,433.694,438.194,442.694,449.192,453.188,457.688,459.938,462.071,465.572,470.072,474.572,479.072,482.069,486.065,489.566,493.067,495.569,500.069,504.065,506.315,508.448,512.444,515.279,518.276,522.272,526.268,528.77,532.271,534.521,536.654,541.154,545.654" svgx:width="0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.55,0.56,0.33,0.44,0.28,0.28,0.78,0.28,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">after therapy. Preliminary data showed suppressive effects by </text>
   <text y="532.897" x="310.025,316.028,322.526,327.026,331.526,336.602,342.605,349.103,353.603,358.103,363.179,365.96,371.963,377.966,381.962,386.462,389.243,393.743,398.243,401.024,407.027,413.525,418.025,423.101,425.72,431.057,433.838,437.834,441.83,444.332,446.834,450.335,453.116,457.616,460.613,465.113,467.615,470.117,473.114,477.11,480.107,484.103,486.605,489.107,493.607,498.107,500.888,507.89,511.886,516.386,518.888,522.884,525.386,529.382,533.882,536.663,541.163,545.663" svgx:width="0.67,0.72,0.5,0.5,0.56,0.67,0.72,0.5,0.5,0.56,0.25,0.67,0.67,0.44,0.5,0.25,0.5,0.5,0.25,0.67,0.72,0.5,0.56,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD19+CD25+ BReg on CD4+ T cells proliferation mediated by </text>
   <text y="543.895" x="310.025,313.022,318.521,321.518,326.018,330.518,332.768,333.848,337.844,340.346,342.596,343.676,348.176,351.173,358.175,362.675,367.175,369.677,374.177,377.678,379.928,381.008,385.508,388.505,390.755,391.835,394.832,397.334,401.834,406.334,410.834,413.336,415.838,422.84,427.34,431.84,434.09,436.34,437.42,443.918,448.418,450.92,454.916,459.416,461.666,462.746,469.244,473.24,476.741,478.991,480.071,484.571,489.071,491.573,493.823,494.903,498.899,503.399,507.899,511.895,514.892,518.888,523.388,525.89,528.14,529.22,533.216,536.213,538.715,542.711,545.708" svgx:width="0.33,0.61,0.33,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.44,0.33,0.44,0.5,0.28,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IL-10 at 3-months of fingolimod, which was not apparent after </text>
   <text y="554.893" x="310.025,316.028,320.528,325.028,329.024,333.524,338.024,342.524,346.52" svgx:width="0.67,0.5,0.5,0.44,0.5,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Copaxone.</text>
   <text y="565.891" x="310.025,316.523,321.023,326.027,330.023,332.525,337.529,341.03,343.532,348.032,353.036,356.537,359.534" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="565.891" x="362.324,368.822,373.322,376.319,379.109,383.609,387.605,390.107,394.103,396.893,403.895,407.891,412.391,415.181,419.177,423.677,426.179,430.175,434.675,439.175,441.965,446.465,450.965,453.755,456.257,460.757,464.753,467.543,472.043,474.545,477.38,480.377,484.373,487.37,491.366,495.866,498.368,501.158,508.16,512.156,516.152,520.652,524.648,529.148,531.65,535.151,542.153,545.654" svgx:width="0.72,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.25,0.78,0.44,0.5,0.25,0.44,0.5,0.28,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our data may extend on the different mechanisms </text>
   <text y="576.889" x="310.025,314.525,317.522,319.772,322.769,325.271,329.771,334.271,338.771,341.273,343.775,350.777,355.277,359.777,362.027,366.023,370.523,375.023,377.273,381.269,385.769,390.269,394.265,398.765,403.265,407.765,411.761,414.011,416.513,421.013,423.263,431.264,436.268,438.518,441.02,448.022,455.024,459.524,464.024,468.524,471.521,475.517,480.017,484.517,487.019,491.015,493.517,496.019,500.519,505.019" svgx:width="0.5,0.33,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.5,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of fingolimod and copaxone in MS immunoregulation.</text>
   <text y="603.889" x="310.025,315.524,320.024,324.524" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P972</text>
   <text y="614.887" x="310.025,316.523,321.023,326.027,328.529,333.533,335.783,338.033,341.534,346.538,350.039,353.036,357.536,360.038,365.042,369.038,374.042,376.292,380.792,385.796,390.8,393.05,397.046,401.042,405.542,409.538,413.534,417.035,419.537,424.541,427.043,431.039,433.289,438.293,443.297,447.797,451.793,459.29,463.79,467.786,472.286,477.29,481.79,486.794,491.294,498.791,501.293,505.289,508.79,511.04,515.54,518.537" svgx:width="0.72,0.5,0.56,0.28,0.56,0.25,0.25,0.39,0.56,0.39,0.33,0.5,0.28,0.56,0.44,0.56,0.25,0.5,0.56,0.56,0.25,0.44,0.44,0.5,0.44,0.44,0.39,0.28,0.56,0.28,0.44,0.25,0.56,0.56,0.5,0.44,0.83,0.5,0.44,0.5,0.56,0.5,0.56,0.5,0.83,0.28,0.44,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Rapid, sustained and reversible pharmacodynamics of </text>
   <text y="625.885" x="310.025,316.523,323.021,329.519,331.769,338.771,345.269,350.768,353.018,355.52,360.524,362.774,371.27,376.274,378.524,383.528,388.028,391.025,393.527,397.523,402.527,405.524,409.025,411.275,414.776,419.78,424.784,429.788,434.288,438.284,441.281,444.782,447.032,454.529,458.525,462.521,467.525,472.025,477.029,479.531,483.032,490.529,492.779,497.279,500.276,502.526,507.026,511.022,514.019,516.521,521.021,526.025" svgx:width="0.72,0.72,0.72,0.25,0.78,0.72,0.61,0.25,0.28,0.56,0.25,0.94,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.39,0.56,0.56,0.56,0.5,0.44,0.33,0.39,0.25,0.83,0.44,0.44,0.56,0.5,0.56,0.28,0.39,0.83,0.25,0.5,0.33,0.25,0.5,0.44,0.33,0.28,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">DAC HYP in MS patients supports mechanism of action </text>
   <text y="636.883" x="310.025,314.525,317.027,321.527,323.777,331.274,335.774,340.778,345.782,348.284,352.784,355.781,358.283,362.783,367.787,370.037,374.537,377.534,379.784,382.781,387.785,391.781,394.031,397.532,403.535,406.532,411.032,413.282,418.286,422.786,425.783,430.787,437.285,441.785" svgx:width="0.5,0.28,0.5,0.25,0.83,0.5,0.56,0.56,0.28,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.33,0.56,0.44,0.25,0.39,0.67,0.33,0.5,0.25,0.56,0.5,0.33,0.56,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">via modulation of the IL-2 pathway</text>
   <text y="647.881" x="310.025,316.523,318.773,326.774,330.77,335.27,337.772" svgx:width="0.72,0.25,0.89,0.44,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">D Mehta</text>
   <text y="645.439" x="341.758" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="647.959" x="344.683,346.933,349.183,355.681,357.931,363.934,367.93,370.432,373.933,376.435,380.431" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.28,0.39,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K Reister</text>
   <text y="645.439" x="383.428" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="647.959" x="386.353,388.603,390.853,394.354,396.604,401.608,406.108,410.104,413.101,415.603,420.103,424.099" svgx:width="0.25,0.25,0.39,0.25,0.56,0.5,0.44,0.33,0.28,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Sheridan</text>
   <text y="645.439" x="428.598" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="647.959" x="431.523,433.773,436.023,439.524,441.774,447.273,449.775,454.275,456.777,461.277" svgx:width="0.25,0.25,0.39,0.25,0.61,0.28,0.5,0.28,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Elkins</text>
   <text y="645.439" x="464.778" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="647.959" x="467.703,469.953,472.203,477.702,479.952,486.45,493.452,497.448,500.445,504.441,508.941,512.937,517.437" svgx:width="0.25,0.25,0.61,0.25,0.72,0.78,0.44,0.33,0.44,0.5,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Amaravadi</text>
   <text y="645.439" x="519.938" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="656.437" x="310.017" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="658.959" x="312.941,318.44,320.942,325.442,329.942,333.938,338.438,340.688,343.685,348.185,352.181,356.177,358.427,360.677,366.68,371.18,377.678,382.178,385.679,388.181,392.681,397.181,401.177,403.427,405.677,413.174,418.673,420.923,423.173,429.671,434.171,436.673,439.175,443.171,447.671,449.921,454.421,456.923,461.423,463.925,467.921,471.422,473.672" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec, Cambridge, MA, United States, </text>
   <text y="656.439" x="475.92" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="658.959" x="478.845,484.344,488.844,493.344,497.34,499.842,503.838" svgx:width="0.61,0.5,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Abbvie </text>
   <text y="669.957" x="310.014,315.513,318.015,322.515,325.017,329.517,333.513,337.014,341.514,346.014,350.01,354.51,357.012,359.514,363.51,367.011,369.261,372.258,376.758,380.754,383.004,385.254,387.504,393.003,396.999,401.499,407.502,412.002,416.502,421.002,423.252,429.255,431.757,434.259,438.255,440.505,442.755,448.758,454.257,456.507,458.757,465.255,469.755,472.257,474.759,478.755,483.255,485.505,490.005,492.507,497.007,499.509,503.505" svgx:width="0.61,0.28,0.5,0.28,0.5,0.44,0.39,0.5,0.5,0.44,0.5,0.28,0.28,0.44,0.39,0.25,0.33,0.5,0.44,0.25,0.25,0.25,0.61,0.44,0.5,0.67,0.5,0.5,0.5,0.25,0.67,0.28,0.28,0.44,0.25,0.25,0.67,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biotherapeutics Inc., Redwood City, CA, United States</text>
   <text y="696.957" x="310.014,316.017,320.517,324.513,329.517,334.017,337.851,342.351,347.355,352.359,357.363,360.36" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="696.957" x="365.121,371.619,375.615,379.611,382.113,384.615,388.611,393.111,400.113,404.109,408.609,410.859,413.37,417.87,420.372,424.872,429.372,432.369,436.869,439.371,443.367,445.869,450.369,452.619,455.13,459.63,462.627,467.127,471.123,475.119,478.62,482.121,484.371,486.882,489.879,496.377,502.875,508.878,511.128,513.639,520.137,526.635,531.639,534.636,536.886,539.136,541.647,545.643" svgx:width="0.72,0.44,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.25,0.55,0.33,0.72,0.72,0.67,0.25,0.55,0.72,0.72,0.56,0.33,0.25,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Daclizumab high-yield process (DAC HYP), a </text>
   <text y="707.955" x="310.014,314.514,319.014,326.016,330.012,334.512,337.014,341.01,345.006,349.506,351.756,354.123,357.12,361.62,368.118,372.618,374.868,377.235,384.237,388.737,393.237,397.737,401.733,404.235,408.735,413.235,417.231,419.733,421.983,424.35,428.346,432.846,435.348,437.85,442.35,446.85,451.35,455.265,457.515,459.765,462.132,466.632,469.134,473.634,478.134,481.635,483.885,486.252,489.249,494.748,497.745,502.245,504.495,506.862,509.859,513.855,517.851,521.847,526.347,528.849,533.349,536.346,538.596,540.963,545.679" svgx:width="0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.44,0.5,0.25,0.55,0.33,0.5,0.72,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.52,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">humanized IgG1 monoclonal antibody, binds IL-2 receptor α </text>
   <text y="718.953" x="310.014,314.01,318.51,322.506,325.008,329.508,331.416,334.413,337.41,342.909,345.906,350.406,356.409,361.125,363.033,367.533,370.53,372.447,378.45,384.948,389.448,393.948,396.945,398.853,402.849,407.349,411.849,413.757,418.257,420.759,425.259,429.255,433.755,437.256,439.173,443.169,446.67,450.171,454.671,458.667,461.169,465.165,467.667,470.169,474.669,479.169,481.077,485.577,488.574,490.482,493.479,498.978,501.975,506.475,508.725,510.633,513.135,517.635,522.135,524.637,529.137,531.639,534.141,536.643,541.143,545.643" svgx:width="0.44,0.5,0.44,0.28,0.5,0.25,0.33,0.33,0.61,0.33,0.5,0.67,0.52,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.44,0.5,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.33,0.61,0.33,0.5,0.25,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">chain (IL-2Rα or CD25) and blocks association of IL-2, inhibiting </text>
   <text y="729.951" x="310.014,314.514,317.016,321.516,326.016,328.167,332.163,334.998,337.995,340.497,344.997,347.499,350.001,354.501,356.652,361.152,365.652,368.154,370.305,374.805,379.305,381.807,383.958,386.46,390.96,393.462,397.458,400.455,407.457,411.453,415.953,418.455,422.451,424.953,428.949,431.1,435.096,437.931,440.928,443.43,447.93,450.432,452.935,457.435,459.586,462.583,468.082,471.079,475.579,481.582,486.163,490.141,492.292,495.289,500.788,503.785,508.285,510.436,513.937,516.439,520.939,525.439,529.435,531.937,534.439,538.939,543.439,545.689" svgx:width="0.5,0.28,0.5,0.5,0.25,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.28,0.44,0.33,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.25,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.61,0.33,0.5,0.67,0.51,0.44,0.25,0.33,0.61,0.33,0.5,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">high affinity but not intermediate affinity IL-2Rβγ IL-2 signaling. </text>
  </g>
 </g>
</svg>
